Back

PRIME Education, Inc. (PRIME®)

  • Carcinoma, Non-Small-Cell Lung

Unpacking Guideline-Directed Combination IO Regimens in First-Line mNSCLC

The management of metastatic non-small cell lung cancer (mNSCLC) is rapidly evolving, with an expanding role of immunotherapy (IO) and combination regimens continually reshaping the clinical guidelines. This interactive Booster Quiz is designed to help you test and refine your knowledge of the latest clinical data for IO-based regimens and biomarker-driven treatment selection in mNSCLC. Test your ability to apply the latest clinical guidelines to real-world clinical practice through this interactive Booster Quiz, featuring: Immediate expert feedback on your answer selections The opportunity to benchmark your performance compared to peers.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.25 creditsAMA PRA Category 1 Credit™Up to 0.25 creditsNursingUp to 0.25 creditsPharmacyUp to 0.25 credits

MOC types

ABIM — Medical KnowledgeUp to 0.25 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.25 credits
  • MOC · Up to 0.25 points
  • Commercial Support
  • Released
    Jun 18, 2026
  • Last day to claim credit
    Jun 18, 2027 8 months left